{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T18:00:26Z","timestamp":1771783226170,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,22]]},"DOI":"10.7759\/cureus.104071","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T17:37:03Z","timestamp":1771781823000},"source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal Tumor of the Hand Causing Tumor-Induced Osteomalacia"],"prefix":"10.7759","author":[{"given":"Andrew","family":"Cecil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meti","family":"Shagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Basit","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ali A","family":"Gardezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-induced osteomalacia: a comprehensive review","volume":"44","author":"Minisola S","year":"2023","unstructured":"Minisola S, Fukumoto S, Xia W, et al.. Tumor-induced osteomalacia: a comprehensive review. Endocr Rev. 2023, 44:323-53. 10.1210\/endrev\/bnac026","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"Jan de Beur SM","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia WB, et al.. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med. 2023, 293:309-28. 10.1111\/joim.13593","journal-title":"J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-01005-8","article-title":"Tumor-induced osteomalacia: a systematic clinical review of 895 cases","volume":"111","author":"Bosman A","year":"2022","unstructured":"Bosman A, Palermo A, Vanderhulst J, et al.. Tumor-induced osteomalacia: a systematic clinical review of 895 cases. Calcif Tissue Int. 2022, 111:367-79. 10.1007\/s00223-022-01005-8","journal-title":"Calcif Tissue Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07527-9","article-title":"Postoperative outcome and clinical management of tumor-induced osteomalacia: a single-center retrospective cohort study on 117 patients","volume":"36","author":"Shan C","year":"2025","unstructured":"Shan C, Wei Z, Li S, et al.. Postoperative outcome and clinical management of tumor-induced osteomalacia: a single-center retrospective cohort study on 117 patients. Osteoporos Int. 2025, 36:1919-30. 10.1007\/s00198-025-07527-9","journal-title":"Osteoporos Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000001163","article-title":"Performance of 68Ga-DOTA-SST PET\/CT, octreoscan SPECT\/CT and 18F-FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis","volume":"41","author":"Jiang Y","year":"2020","unstructured":"Jiang Y, Hou G, Cheng W. Performance of 68Ga-DOTA-SST PET\/CT, octreoscan SPECT\/CT and 18F-FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis. Nucl Med Commun. 2020, 41:370-6. 10.1097\/MNM.0000000000001163","journal-title":"Nucl Med Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000001379","article-title":"Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET\/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis","volume":"42","author":"Agrawal K","year":"2021","unstructured":"Agrawal K, Padhy BM, Meher BR, Mohanty RR. Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET\/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis. Nucl Med Commun. 2021, 42:646-55. 10.1097\/MNM.0000000000001379","journal-title":"Nucl Med Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101826","article-title":"Burosumab: current status and future prospects","volume":"38","author":"Goyal A","year":"2024","unstructured":"Goyal A, Tandon N. Burosumab: current status and future prospects. Best Pract Res Clin Endocrinol Metab. 2024, 38:101826. 10.1016\/j.beem.2023.101826","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi Y","year":"2021","unstructured":"Imanishi Y, Ito N, Rhee Y, et al.. Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia. J Bone Miner Res. 2021, 36:262-70. 10.1002\/jbmr.4184","journal-title":"J Bone Miner Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4900","article-title":"Burosumab improves patient-reported outcomes in adults with tumor-induced osteomalacia: mixed-methods analysis","volume":"38","author":"Jan de Beur SM","year":"2023","unstructured":"Jan de Beur SM, Cimms T, Nixon A, et al.. Burosumab improves patient-reported outcomes in adults with tumor-induced osteomalacia: mixed-methods analysis. J Bone Miner Res. 2023, 38:1654-64. 10.1002\/jbmr.4900","journal-title":"J Bone Miner Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07342-2","article-title":"Diagnostic efficiency of (68)Ga-DOTANOC PET\/CT in patients with suspected tumour-induced osteomalacia","volume":"31","author":"He Q","year":"2021","unstructured":"He Q, Zhang B, Zhang L, et al.. Diagnostic efficiency of (68)Ga-DOTANOC PET\/CT in patients with suspected tumour-induced osteomalacia. Eur Radiol. 2021, 31:2414-21. 10.1007\/s00330-020-07342-2","journal-title":"Eur Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche D","year":"2016","unstructured":"El-Maouche D, Sadowski SM, Papadakis GZ, et al.. (68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2016, 101:3575-81. 10.1210\/jc.2016-2052","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000290","article-title":"A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter JM","year":"2015","unstructured":"Carter JM, Caron BL, Dogan A, Folpe AL. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol. 2015, 39:75-83. 10.1097\/PAS.0000000000000290","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang H","year":"2015","unstructured":"Wang H, Zhong D, Liu Y, et al.. Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up. J Bone Joint Surg Am. 2015, 97:1084-94. 10.2106\/JBJS.N.01299","journal-title":"J Bone Joint Surg Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1756-1","article-title":"Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients","volume":"18","author":"Zuo QY","year":"2017","unstructured":"Zuo QY, Wang H, Li W, et al.. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. BMC Musculoskelet Disord. 2017, 18:403. 10.1186\/s12891-017-1756-1","journal-title":"BMC Musculoskelet Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong WH","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, et al.. Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res. 2013, 28:1386-98. 10.1002\/jbmr.1881","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14217870","article-title":"Serum phosphorus is a fast and highly sensitive marker predictive of a complete cure of tumor-induced osteomalacia","volume":"14","author":"Kim SH","year":"2025","unstructured":"Kim SH, Lee YH, Hong N, Cho S, Rhee Y. Serum phosphorus is a fast and highly sensitive marker predictive of a complete cure of tumor-induced osteomalacia. J Clin Med. 2025, 14:7870. 10.3390\/jcm14217870","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf148","article-title":"Skeletal involvement in tumor-induced osteomalacia","volume":"41","author":"Minisola S","year":"2026","unstructured":"Minisola S, Colangelo L, Pepe J, Cipriani C, Corsi A. Skeletal involvement in tumor-induced osteomalacia. J Bone Miner Res. 2026, 41:104-11. 10.1093\/jbmr\/zjaf148","journal-title":"J Bone Miner Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-024-01249-6","article-title":"Long-term follow-up data of tumor-induced osteomalacia managed with surgery and\/or radiofrequency ablation from a single center","volume":"115","author":"Memon SS","year":"2024","unstructured":"Memon SS, Patel MA, Lila A, et al.. Long-term follow-up data of tumor-induced osteomalacia managed with surgery and\/or radiofrequency ablation from a single center. Calcif Tissue Int. 2024, 115:242-50. 10.1007\/s00223-024-01249-6","journal-title":"Calcif Tissue Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/461395-mesenchymal-tumor-of-the-hand-causing-tumor-induced-osteomalacia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T17:37:04Z","timestamp":1771781824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/461395-mesenchymal-tumor-of-the-hand-causing-tumor-induced-osteomalacia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.104071","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,22]]}}}